Aurora urges shareholders to reject Curaleaf's undervalued hostile takeover bid.

Aurora Cannabis has urged its shareholders to reject Curaleaf Holdings' hostile takeover bid, calling it significantly undervalued and risky. Aurora, a debt-free company with $149 million in cash, warns that Curaleaf's offer would expose shareholders to Curaleaf's over $1 billion debt and weaken their voting rights. The Board unanimously recommends shareholders take no action and not tender their shares, emphasizing Aurora's strong growth prospects and superior standalone value. Shareholders are advised to withdraw any shares already tendered to Curaleaf and stay informed via Aurora's official channels.